Anxiolytic-like effects of sanjoinine A isolated from Zizyphi Spinosi Semen: Possible involvement of GABAergic transmission

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 2, 2009, Pages 206-213

  Han, Huishan ^a   Ma, Yuan ^a   Eun, Jae Soon ^b   Li, RiHua ^b   Hong, Jin Tae ^a   Lee, Myung Koo ^a   Oh, Ki Wan ^a  

^a Chungbuk National University   (South Korea)

^b Woosuk University   (South Korea)

Author keywords

Anxiolytic like effect; Chloride influx; Elevated plus maze; GABAA subunits; Glutamic acid decarboxylase; Grip strength; Hole board; Locomotor; Open field; Zizyphi Spinosi Semen (ZSS)

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DIAZEPAM; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; HERBACEOUS AGENT; RECEPTOR SUBUNIT; SANJOININE A; UNCLASSIFIED DRUG; ZIZYPHI SPINOSI SEMEN EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; GABAERGIC TRANSMISSION; GRANULE CELL; GRIP STRENGTH; HOLE BOARD TEST; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PLANT SEED; PRIORITY JOURNAL; RHAMNACEAE; TRANQUILIZING ACTIVITY; ZIZYPHI SPINOSI SEMEN;

ANIMALS; ANTI-ANXIETY AGENTS; CELLS, CULTURED; GAMMA-AMINOBUTYRIC ACID; HAND STRENGTH; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; ZIZIPHUS;

EID: 59649096943     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.11.012     Document Type: Article

References (47)

1. Adzu B., Amos S., Dzarma S., Wambebe C., and Gamaniel K. Effect of Zizyphus spina-christi wild aqueous extract on the central nervous system in mice. J Ethnopharmacol 79 (2002) 13-16
2. Ahn N.Y., Jung J.W., Oh H.R., Shin J.S., and Hyeon S.Y. Anxiolytic-like effects of Sanjoin-Tang extracts and its ingredients in the elevated plus-maze in mice. J Appl Pharmacol 12 (2004) 151-156
3. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., et al. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50 (1998) 291-313
4. A receptor: an old target with new potential?. Sleep Med 5 (2004) 9-15
5. Beck A.T. Cognitive approaches to panic: theory and therapy. In: Mater J.D., and Rachman S. (Eds). Panic: psychological perspective (1988), Lawrence Erlbaum Associates, Hillsdale
6. Bonnert T.P., McKernan R.M., Farrar S., le Bourdellès B., Heavens R.P., and Smith D.W. θ, a novel γ-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci U S A 96 (1999) 9891-9896
7. Brailowsky S., and Garcia O. Ethanol, GABA and epilepsy. Arch Med Res 30 (1999) 3-9
8. Bu D.F., Erlander M.G., Hitz B.C., Tillakaratne N.J., Kaufman D.L., and Wagner-McPherson C.B. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A 89 (1992) 2115-2119
9. Chen S.W., Xin Q., Kong W.X., Min L., and Li J.F. Anxiolytic-like effect of succinic acid in mice. Life Sci 773 (2003) 3257-3264
10. Cheng G., Bai Y.J., Zhao Y.Y., Yao J., Liu Y., Tu G.Z., et al. Flavonoids from Zizyphus jujube Mill var. Spinosa. Tetrahedron 56 (2000) 8915-8920
11. Chung K.F., and Lee C.K. Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents. Gen Hosp Psych 24 (2002) 430-435
12. Davies M., Bateson A.N., and Dunn S.M. Molecular biology of the GABA(A) receptor: functional domains implicated by mutational analysis. Front Biosci 1 (1996) d214-d233
13. de Melo C.T., Monteiro A.P., Leite C.P., de Araújo F.L., Lima V.T., and Barbosa-Filho J.M. Anxiolytic-like effects of (O-methyl)-N-2,6-dihydroxybenzoyl-tyramine (riparin III) from Aniba riparia (Nees) Mez (Lauraceae) in mice. Biol Pharm Bull 29 (2005) 451-454
14. Di Lazzaro V., Pilato F., Dileone M., Ranieri F., Ricci V., and Profice P. GABAA receptor subtype specific enhancement of inhibition in human motor cortex. J Physiol 575 (2006) 721-726
15. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., and Van Rompay M. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Complement Ther Med 7 (1998) 1569-1575
16. Friede M., and Freudenstein J. Antidepressant and anxiolytic effect of St. John's wort extract ZE-117. Eur Psychiatry 17 (2002) 96
17. Gardner C.R., Tully W.R., and Hedgecock C.J. The rapidly expanding range of neuronal benzodiazepine receptor ligands. Prog Neurobiol 40 (1993) 1-61
18. Graham D., Faure C., Besnard F., and Langer S.Z. Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes. Eur Neuropsychopharmacol 6 (1996) 119-125
19. Han H.S., Ma Y., Eun J.S., Hong J.T., and Oh K.W. Anxiolytic-like effect of methanol extract of Zizyphi Spinosi Semen in mice. J Appl Pharmacol 15 (2007) 175-181
20. Hertz L., Zhao Z., and Chen Y. The astrocytic GABA(A)/benzodiazepine-like receptor: the Joker receptor for benzodiazepine-mimetic drugs?. Recent Pat CNS Drug Discov 1 (2006) 93-103
21. Houston C.M., and Smart T.G. CaMK-II modulation of GABA(A) receptors expressed in HEK293, NG108-15 and rat cerebellar granule neurons. Eur J Neurosci 24 (2006) 2504-2514
22. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., and Baur R. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol 64 (2002) 1415-1424
23. Kaupmann K., Huggel K., Heid J., Flor P.J., Bischoff S., and Mickel S.J. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 386 (1997) 239-246
24. Kehl L.J., Trempe T.M., and Hargreaves K.M. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 85 (2000) 333-343
25. Klodzinska A., Tatarczyńska E., Chojnacka-Wójcik E., Nowak G., Cosford N.D., and Pilc A. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Neuropharmacology 47 (2004) 342-350
26. Korpi E.R., Mihalek R.M., Sinkkonen S.T., Hauer B., Hevers W., and Homanics G.E. Altered receptor subtypes in the forebrain of GABAA receptor δ subunit-deficient mice: recruitment of γ2 subunits. Neuroscience 109 (2002) 733-743
27. Lee S.S., Lin B.F., and Liu K.C. Three triterpene esters from Zizyphus jujuba. Phytochemistry 43 (1996) 847-851
28. Ma Y., Han H., Eun J.S., Kim H.C., Hong J.T., and Oh K.W. Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital-induced sleeping behaviors through the modification of GABA-ergic systems. Biol Pharm Bull 30 (2007) 1748-1753
29. Nolan N.A., and Parkes M.W. The effects of benzodiazepines on the behavior of mice on a hole-board. Psychopharmacologia 29 (1973) 277-286
30. Park J.H., Lee H.J., Koh S.B., Ban J.Y., and Seong Y.H. Protection of NMDA-induced neuronal cell damage by methanol extract of Zizyphi Spinosi Semen in cultured rat cerebellar granule cells. J Ethnopharmacol 95 (2004) 39-45
31. Park J.H., Cha H.Y., Seo J.J., Hong J.T., Han K., and Oh K.W. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Prog Neuro-psychopharmacol Biol Psychiatry 29 (2005) 895-900
32. Peng Z.C., and Zhu J.J. Research advances in chemical constituents and pharmacological effects of semen Ziziphi Spinosae. Lishizhen Med Medica Res 12 (2001) 86-87
33. Peng W.H., Hsieh M.T., Lee Y.S., Lin Y.C., and Liao J. Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety. J Ethnopharmacol 72 (2000) 435-441
34. Rex A., Morgenster E., and Fink H. Anxiolytic-like effects of Kava-Kava in the elevated plus-maze test-a comparison with diazepam. Prog Neuro-psychopharmacol Biol Psychiatry 26 (2002) 855-860
35. Rickels K., Garcia-Espana F., Mandos L.A., and Case G.W. Physician withdrawal checklist (PWC-20). J Clin Psychopharmacol 28 (2008) 447-451
36. Rouillon F. Anxiety with depression: a treatment need. Eur Neuropsychopharmacol 3 (1999) 87-92
37. Silva M.I., de Aquino Neto M.R., Teixeira Neto P.F., Moura B.A., do Amaral J.F., and de Sousa D.P. Central nervous system activity of acute administration of isopulegol in mice. Pharmacol Biochem Behav 88 (2007) 141-147
38. Takeda H., Tsuji M., and Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 350 (1998) 21-29
39. Thompson C.L., Pollard S., and Stephenson F.A. Developmental regulation of expression of GABAA receptor alpha 1 and alpha 6 subunits in cultured rat cerebellar granule cells. Neuropharmacology 35 (1996) 1337-1346
40. Une H.D., Sarveiya V.P., Pal S.C., Kasture V.S., and Kasture S.B. Nootropic and anxiolytic activity of saponins of Albizzia lebbeck leaves. Pharmacol Biochem Behav 69 (2001) 439-444
41. Wei X.Y., Yang J.Y., Wang J.H., and Wu C.F. Anxiolytic effect of saponins from Panax quinquefolium in mice. J Ethnopharmacol 111 (2007) 613-618
42. Weiss S.M., Wadsworth G., Fletcher A., and Dourish C.T. Utility of ethological analysis to overcome locomotor confounds in elevated plus-maze of anxiety. Neurosci Behav Rev 23 (1998) 265-271
43. West M.R., and Molloy C.R. A microplate assay measuring chloride ion channel activity. Anal Biochem 241 (1996) 51-58
44. Whiting P.J. The GABA-A receptor gene family: new targets for therapeutic intervention. Neurochem Int 34 (1999) 387-390
45. Youssef N.A., and Rich C.L. Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann Clin Psychiatry 20 (2008) 157-169
46. A receptors in the anxiolytic-like effects of Cinnamomum cassia in mice. Pharmacol Biochem Behav 87 (2007) 164-170
47. Yuzurihara M., Ikarashi Y., Ishige A., Sasaki H., and Maruyama Y. Anxiolytic-like effect of saiboku-to, an oriental herbal medicine on histaminergics-induced anxiety in mice. Pharmacol Biochem Behav 67 (2000) 489-495